News - Otsuka, brexpiprazole

Filter

Current filters:

Otsukabrexpiprazole

Popular Filters

US psychiatrists’ views on prescribing Otsuka/Lundbeck’s brexpiprazole

26-06-2014

Surveyed US psychiatrists are receptive to novel adjunctive therapies to antidepressants for treatment-resistant…

brexpiprazoleBrintellixLundbeckMarkets & MarketingNeurologicalOtsukaPharmaceuticalUSA

Lundbeck and Otsuka’s brexpiprazole shows efficacy in Phase III trial

Lundbeck and Otsuka’s brexpiprazole shows efficacy in Phase III trial

24-01-2014

Danish CNS drug specialist Lundbeck (LUND: CO) and Japanese drug maker Otsuka (TYO: 4768) have revealed…

brexpiprazoleDenmarkLundbeckNeurologicalOtsukaPharmaceuticalResearch

Otsuka and Lundbeck expand current Abilify collaboration

07-03-2013

Japanese drugmaker Otsuka Pharmaceutical (TYO: 4578) and Denmark-based CNS specialist Lundbeck (LUND:…

AbilifyAbilify MaintenabrexpiprazoleEuropeLicensingLundbeckMarkets & MarketingNeurologicalOtsukaPharmaceutical

Back to top